Clinical Trial: Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916325) titled 'Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion' on March 21.

Brief Summary: The purpose of this clinical study is to confirm the safety and effectiveness of dual hypothermic oxygenated perfusion (DHOPE) using the Liver Assist to preserve deceased donor livers for transplantation.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Liver Transplant Surgery Liver Transplantation

Intervention: DEVICE: dual hypothermic oxygenated perfusion (DHOPE)

Clinically, end-ischemic DHOPE has been shown to restore hepatic ATP, reduce reperfusion injury, and improve outcomes afte...